MicroRNA‑200b inhibits pituitary tumor cell proliferation and invasion by targeting PKCα

Wang,Yuanchuan; Yin,Xiaohong; Zhao,Long; Li,Shun; Duan,Jie; Kuang,Renzhao; Duan,Junwei

doi:10.3892/etm.2017.4681

MicroRNA‑200b inhibits pituitary tumor cell proliferation and invasion by targeting PKCα

Authors:
- Yuanchuan Wang
- Xiaohong Yin
- Long Zhao
- Shun Li
- Jie Duan
- Renzhao Kuang
- Junwei Duan
View Affiliations

Affiliations: Department of Neurosurgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China
Published online on: June 27, 2017 https://doi.org/10.3892/etm.2017.4681
Pages: 1706-1714

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the expression of miR‑200b and protein kinase Cα (PKCα) in pituitary tumors and to determine whether miR‑200b may inhibit proliferation and invasion of pituitary tumor cells. The regulation of PKCα expression was targeted in order to find novel targets for the treatment of pituitary tumors. In total, 53 pituitary tumor tissue samples were collected; these included 28 cases of invasive pituitary tumors and 25 cases of non‑invasive tumors, in addition to 5 normal pituitaries. The expression level of miR‑200b in the pituitary tumor tissue was detected by quantitative polymerase chain reaction (qPCR) and the expression of PKCα protein was detected by immunohistochemistry. A PKCα 3'untranslated region (UTR) luciferase vector was constructed and a dual luciferase reporter gene assay was employed in order to examine the effect of miR‑200b on the PKCα 3'UTR luciferase activity. AtT‑20 cells were transfected with miR‑200b mimics, PKCα siRNA and miR‑200b mimics + PKCα, and the changes in cellular proliferation, invasion and apoptosis were observed via MTT, Transwell assay and flow cytometric analysis. Furthermore, PKCα mRNA expression was determined by qPCR, and Western blotting was performed to detect the expression of PKCα protein. miR‑200b revealed downregulation in invasive pituitary tumor tissue, and the expression level was significantly down‑regulated compared with normal and non‑invasive pituitary tumor tissue (P<0.01). In addition, the positive rate of PKCα protein expression in invasive pituitary tumor tissues was significantly higher than in normal and non‑invasive tissues (P<0.01). PKCα protein levels are inversely correlated with miR‑200b levels in invasive pituitary tumor tissues (r=‑0.436, P=0.021). The dual luciferase reporter gene assay revealed that miR‑200b could specifically bind to the 3'UTR of PKCα and significantly inhibit the luciferase activity by 39% (P<0.01). Upregulation of miR‑200b or downregulation of PKCα could suppress cell proliferation and invasion, and increase apoptosis of AtT‑20 cells. It was revealed that PKCα siRNA could suppress both proliferation and invasion of AtT‑20 cells and partially simulate the function of miR‑200b. Expression of PKCα mRNA and protein decreased significantly in AtT‑20 cells overexpressing miR‑200b. Additionally, miR‑200b was significantly down‑regulated in invasive pituitary tumor tissue and inversely correlated with PKCα protein levels. In conclusion, miR‑200b inhibited proliferation and invasiveness and promoted the apoptosis of pituitary tumor cells by targeting PKCα. The observations of the present study indicate that miR‑200b and PKCα may serve as promising therapeutic targets for invasive pituitary tumors.

View Figures

View References

1	Gentilin E, Tagliati F, Filieri C, Molè D, Minoia M, Ambrosio M Rosaria, Uberti EC Degli and Zatelli MC: miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cδ. Endocrinology. 154:1690–1700. 2013. View Article : Google Scholar : PubMed/NCBI
2	D'Angelo D, Palmieri D, Mussnich P, Roche M, Wierinckx A, Raverot G, Fedele M, Croce CM, Trouillas J and Fusco A: Altered microRNA expression profile in human pituitary GH adenomas: Down-regulation of miRNA targeting HMGA1, HMGA2 and E2F1. J Clin Endocrinol Metab. 97:E1128–E1138. 2012. View Article : Google Scholar : PubMed/NCBI
3	Yin Z, Williams-Simons L, Parlow AF, Asa S and Kirschner LS: Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis. Mol Endocrinol. 22:380–387. 2008. View Article : Google Scholar : PubMed/NCBI
4	Özsu E, Mutlu GY, Çizmecioğlu FM and Hatun Ş: McCune Albright syndrome in association with excessive GH secretion: Case report. Turk Pediatri Ars. 50:114–117. 2015. View Article : Google Scholar : PubMed/NCBI
5	Lania A and Spada A: G-protein and signalling in pituitary tumours. Horm Res. 71 Suppl 2:S95–S100. 2009.
6	Jiang X and Zhang X: The molecular pathogenesis of pituitary adenomas: An update. Endocrinol Metab (Seoul). 28:245–254. 2013. View Article : Google Scholar : PubMed/NCBI
7	Li XH, Wang EL, Zhou HM, Yoshimoto K and Qian ZR: MicroRNAs in human pituitary adenomas. Int J Endocrinol. 2014:4351712014. View Article : Google Scholar : PubMed/NCBI
8	Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M and Croce CM: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 101:pp. 2999–3004. 2004; View Article : Google Scholar : PubMed/NCBI
9	Stilling G, Sun Z, Zhang S, Jin L, Righi A, Kovācs G, Korbonits M, Scheithauer BW, Kovacs K and Lloyd RV: MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and −493 in pituitary carcinomas. Endocrine. 38:67–75. 2010. View Article : Google Scholar : PubMed/NCBI
10	Butz H, Likó I, Czirják S, Igaz P, Korbonits M, Rácz K and Patócs A: MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas. Pituitary. 14:112–124. 2011. View Article : Google Scholar : PubMed/NCBI
11	Qian ZR, Asa SL, Siomi H, Siomi MC, Yoshimoto K, Yamada S, Wang EL, Rahman MM, Inoue H, Itakura M, et al: Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas. Mod Pathol. 22:431–441. 2009. View Article : Google Scholar : PubMed/NCBI
12	Mao ZG, He DS, Zhou J, Yao B, Xiao WW, Chen CH, Zhu YH and Wang HJ: Differential expression of microRNAs in GH-secreting pituitary adenomas. Diagn Pathol. 5:792010. View Article : Google Scholar : PubMed/NCBI
13	Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, Calin GA, Negrini M, Croce CM and Uberti EC Degli: Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas. J Cell Physiol. 210:370–377. 2007. View Article : Google Scholar : PubMed/NCBI
14	Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T and Margalit H: Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 33:2697–2706. 2005. View Article : Google Scholar : PubMed/NCBI
15	Korpal M, Lee ES, Hu G and Kang Y: The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
16	Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S and Brabletz T: A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
17	Leskela S, Leandro-García LJ, Mendiola M, Barriuso J, Inglada-Pérez L, Muñoz I, Martínez-Delgado B, Redondo A, de Santiago J, Robledo M, et al: The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocr Relat Cancer. 18:85–95. 2011. View Article : Google Scholar : PubMed/NCBI
18	Xia W, Li J, Chen L, Huang B, Li S, Yang G, Ding H, Wang F, Liu N, Zhao Q, et al: MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells. Mol Cell Biochem. 344:261–266. 2010. View Article : Google Scholar : PubMed/NCBI
19	Basu A and Sivaprasad U: Protein kinase Cepsilon makes the life and death decision. Cell Signal. 19:1633–1642. 2007. View Article : Google Scholar : PubMed/NCBI
20	Petiti JP, Gutiérrez S, De Paul AL, Andreoli VCM, Ldel V Sosa, Bocco JL and Torres AI: GH3B6 pituitary tumor cell proliferation is mediated by PKCalpha and PKCepsilon via ERK 1/2-dependent pathway. Cell Physiol Biochem. 26:135–146. 2010. View Article : Google Scholar : PubMed/NCBI
21	Hardy J and Vezina JL: Transsphenoidal neurosurgery of intracranial neoplasm. Adv Neurol. 15:261–273. 1976.PubMed/NCBI
22	Knosp E, Steiner E, Kitz K and Matula C: Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 33:610–618. 1993. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Zhao A, Zeng Q, Xie X, Zhou J, Yue W, Li Y and Pei X: MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression. J Genet Genomics. 39:29–35. 2012. View Article : Google Scholar : PubMed/NCBI
25	Hu X, Xin Y, Xiao Y and Zhao J: Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma. Pathol Oncol Res. 20:805–811. 2014. View Article : Google Scholar : PubMed/NCBI
26	He L and Hannon GJ: MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004. View Article : Google Scholar : PubMed/NCBI
27	Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al: MicroRNA expression profiles classify human cancers. Nature. 435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
28	Fabian MR, Sonenberg N and Filipowicz W: Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
29	McManus MT: MicroRNAs and cancer. Semin Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
30	Muralidhar GG and Barbolina MV: The miR-200 Family: Versatile players in epithelial ovarian cancer. Int J Mol Sci. 16:16833–16847. 2015. View Article : Google Scholar : PubMed/NCBI
31	Chang L, Guo F, Huo B, Lv Y, Wang Y and Liu W: Expression and clinical significance of the microRNA-200 family in gastric cancer. Oncol Lett. 9:2317–2324. 2015.PubMed/NCBI
32	Bracken CP, Khew-Goodall Y and Goodall GJ: Network-Based Approaches to Understand the Roles of miR-200 and Other microRNAs in Cancer. Cancer Res. 75:2594–2599. 2015. View Article : Google Scholar : PubMed/NCBI
33	Liu W, Qi L, Lv H, Zu X, Chen M, Wang J, Liu L, Zeng F and Li Y: MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy. BMC Cancer. 15:922015. View Article : Google Scholar : PubMed/NCBI
34	Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y and Baba H: MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol. 19 Suppl 3:S656–S664. 2012. View Article : Google Scholar : PubMed/NCBI
35	Yue CH, Huang CY, Tsai JH, Hsu CW, Hsieh YH, Lin H and Liu JY: MZF-1/Elk-1 Complex Binds to Protein Kinase Cα Promoter and Is Involved in Hepatocellular Carcinoma. PLoS One. 10:e01274202015. View Article : Google Scholar : PubMed/NCBI
36	Chen H, Yu Y, Rong S and Wang H: Evaluation of diagnostic accuracy of DNA methylation biomarkers for bladder cancer: A systematic review and meta-analysis. Biomarkers. 19:189–197. 2014. View Article : Google Scholar : PubMed/NCBI
37	Hsu YH, Yao J, Chan LC, Wu TJ, Hsu JL, Fang YF, Wei Y, Wu Y, Huang WC, Liu CL, et al: Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer. Cancer Res. 74:4822–4835. 2014. View Article : Google Scholar : PubMed/NCBI
38	Humphries B, Wang Z, Oom AL, Fisher T, Tan D, Cui Y, Jiang Y and Yang C: MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis. Carcinogenesis. 35:2254–2263. 2014. View Article : Google Scholar : PubMed/NCBI
39	Sliva D, English D, Lyons D and Lloyd FP Jr: Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB. Biochem Biophys Res Commun. 290:552–557. 2002. View Article : Google Scholar : PubMed/NCBI
40	Tam WL, Lu H, Buikhuisen J, Soh BS, Lim E, Reinhardt F, Wu ZJ, Krall JA, Bierie B, Guo W, et al: Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells. Cancer Cell. 24:347–364. 2013. View Article : Google Scholar : PubMed/NCBI
41	Konopatskaya O and Poole AW: Protein kinase Calpha: Disease regulator and therapeutic target. Trends Pharmacol Sci. 31:8–14. 2010. View Article : Google Scholar : PubMed/NCBI
42	Urtreger AJ, Kazanietz MG and Bal de Kier Joffé ED: Contribution of individual PKC isoforms to breast cancer progression. IUBMB Life. 64:18–26. 2012. View Article : Google Scholar : PubMed/NCBI
43	Vrba L, Garbe JC, Stampfer MR and Futscher BW: Epigenetic regulation of normal human mammary cell type-specific miRNAs. Genome Res. 21:2026–2037. 2011. View Article : Google Scholar : PubMed/NCBI
44	Jadhav SP, Kamath SP, Choolani M, Lu J and Dheen ST: microRNA-200b modulates microglia-mediated neuroinflammation via the cJun/MAPK pathway. J Neurochem. 130:388–401. 2014. View Article : Google Scholar : PubMed/NCBI
45	Tong J, Fu Y, Xu X, Fan S, Sun H, Liang Y, Xu K, Yuan Z and Ge Y: TGF-β1 stimulates human Tenon's capsule fibroblast proliferation by miR-200b and its targeting of p27/kip1 and RND3. Invest Ophthalmol Vis Sci. 55:2747–2756. 2014. View Article : Google Scholar : PubMed/NCBI